(Q45398975)

14 December 2017

Epstein-Barr virus reactivation and multiple sclerosis (English)

1 reference

14 December 2017

0 references

0 references

1

Ø Torkildsen

1 reference

14 December 2017

4

K-M Myhr

1 reference

14 December 2017

H Nyland

2

1 reference

PubMed ID

18042233

14 December 2017

H Myrmel

series ordinal

3

1 reference

14 December 2017

27 November 2007

1 reference

European Journal of Neurology

14 December 2017

1 reference

14 December 2017

15

1 reference

14 December 2017

1

1 reference

14 December 2017

106-108

1 reference

Environmental risk factors for multiple sclerosis. Part I: The role of infection

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.02009.X

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.02009.X

Epstein-Barr virus and disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.02009.X

Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.02009.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.02009.X

10.1111/J.1468-1331.2007.02009.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference

PubMed ID

18042233